Arena Pharma (ARNA) – Analyst EPS Change
-
Arena Pharma's (ARNA) Licensing Deal Is A Match Made In Heaven - Credit Suisse
-
Arena Pharma (ARNA) PT Raised to $55 at Citi; 'Favorable Ph2 Etrasimod UC Data Likely'
-
-
-
-
-
Back to ARNA Stock Lookup